Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Valley National Bancorp Common Stock (VLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Valley National Bancorp Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Valley National Bancorp Common Stock trades at $12.62 (market cap $7.05B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Valley National Bancorp Common Stock pays a 3.45% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Valley National Bancorp Common Stock for 1 Days on average.
| HALO | VLY | |
|---|---|---|
Market Cap | $12.58B | $7.05B |
Volume | 2,179,278 | 7,669,925 |
Sector | Health | Financials |
52-Week High | $115.22 | $15.19 |
52-Week Low | $61.63 | $9.72 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $9.55B |
Dividend Yield | — | 3.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Valley National Bancorp Common Stock
Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →
